Abstract
Screening for bacteriocin production by strains of lactic acid bacteria from a Tunisian dairy product resulted in the detection of Enterococcus faecium bacteriocin producing strain. The anti-microbial compounds produced by this novel strain were heat stable and inactivated by trypsin, proteinase K and pronase E. Bacteriocins produced inhibited not only the closely related LAB, but also Listeria monocytogenes and Staphylococcus aureus. RP-HPLC purification of the anti-microbial compounds shows two individually active fractions eluted at 25.5 and 38.5 min, respectively. Mass spectrometry analysis showed that E. faecium MMT21 produce two bacteriocins enterocin A (4828.67 Da) and enterocin B (5463.8 Da). This result was confirmed by amplification by PCR of enterocins A and B genes. The novel bacteriocin producing strain E. faecium MMT21 was not haemolytic, sensitive to vancomycin and other clinically relevant antibiotics and was an antilisterial strain. Therefore, it may be useful to improve the safety of fermented food products.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
